On the public citation graph

Weak partitioning chromatography for anion exchange purification of monoclonal antibodies

0 signed · 168 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/bit.21080openalex-snapshot
An exclusion mechanism in ion exchange chromatography
inferredcites →https://doi.org/10.1002/bit.21904openalex-snapshot
High‐throughput screening of chromatographic separations: I. Method development and column modeling
inferredcites →https://doi.org/10.1002/bit.21905openalex-snapshot
High‐throughput screening of chromatographic separations: IV. Ion‐exchange
inferredcites →https://doi.org/10.1002/bit.21906openalex-snapshot
High‐throughput screening of chromatographic separations: III. Monoclonal antibodies on ceramic hydroxyapatite
inferredcites →https://doi.org/10.1002/bit.21907openalex-snapshot
High‐throughput screening of chromatographic separations: II. Hydrophobic interaction
inferredcites →https://doi.org/10.1002/elps.11501401163openalex-snapshot
The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences
inferredcites →https://doi.org/10.1002/pmic.200300430openalex-snapshot
Comparison of the Escherichia coli proteomes for recombinant human growth hormone producing and nonproducing fermentations
inferredcites →https://doi.org/10.1002/pmic.200390023openalex-snapshot
Identification of cellular changes associated with increased production of human growth hormone in a recombinant Chinese hamster ovary cell line
inferredcites →https://doi.org/10.1016/j.chroma.2004.08.151openalex-snapshot
Model-based optimization of a preparative ion-exchange step for antibody purification
inferredcites →https://doi.org/10.1016/j.chroma.2006.06.057openalex-snapshot
Pore size distributions of ion exchangers and relation to protein binding capacity
inferredcites →https://doi.org/10.1016/j.chroma.2007.03.016openalex-snapshot
Application of a chromatography model with linear gradient elution experimental data to the rapid scale-up in ion-exchange process chromatography of proteins
inferredcites →https://doi.org/10.1016/j.chroma.2007.06.012openalex-snapshot
Fragments of protein A eluted during protein A affinity chromatography
inferredcites →https://doi.org/10.1016/j.jchromb.2006.09.026openalex-snapshot
Downstream processing of monoclonal antibodies—Application of platform approaches
inferredcites →https://doi.org/10.1016/s0021-9673(00)81841-5openalex-snapshot
Étude de l'élution non-linéaire en chromatographie en phase liquide préparative
inferredcites →https://doi.org/10.1016/s0021-9673(00)88988-8openalex-snapshot
Framework for maximizing throughput in preparative liquid chromatography
inferredcites →https://doi.org/10.1016/s0021-9673(00)94825-8openalex-snapshot
On the stoichiometric model of electrostatic interaction chromatography for biopolymers
inferredcites →https://doi.org/10.1016/s0021-9673(01)90875-1openalex-snapshot
Retention model for high-performance ion-exchange chromatography
inferredcites →https://doi.org/10.1016/s0021-9673(98)01002-4openalex-snapshot
Use of the steric mass action model in ion-exchange chromatographic process development
inferredcites →https://doi.org/10.1016/s0041-0101(03)00177-6openalex-snapshot
Biopharmaceutical Process Validation
inferredcites →https://doi.org/10.1021/bp050425vopenalex-snapshot
Basic Concepts in Q Membrane Chromatography for Large-Scale Antibody Production
inferredcites →https://doi.org/10.1021/bp070117sopenalex-snapshot
Very Large Scale Monoclonal Antibody Purification: The Case for Conventional Unit Operations
inferredcites →https://doi.org/10.1042/bj0590543openalex-snapshot
Separation of neutral proteins on ion-exchange resins
inferredcites →https://doi.org/10.1080/02648725.2001.10648017openalex-snapshot
Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes
inferredcites →https://doi.org/10.1097/00002371-199705000-00007openalex-snapshot
Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use (1997)
inferredcites →https://doi.org/10.1201/b13997-4openalex-snapshot
Establishing Process Robustness Using Designed Experiments

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4611043openalex-extracted
inferred← citeshttps://doi.org/10.1002/0471266949.bmc160openalex-snapshot
Process Development of Protein Therapeutics
inferred← citeshttps://doi.org/10.1002/0471266949.bmc160.pub2openalex-snapshot
Process Development of Protein Therapeutics
inferred← citeshttps://doi.org/10.1002/9780470444894.ch1openalex-snapshot
Downstream Processing of Monoclonal Antibodies: Current Practices and Future Opportunities
inferred← citeshttps://doi.org/10.1002/9780470444894.ch7openalex-snapshot
Integrated Polishing Steps for Monoclonal Antibody Purification
inferred← citeshttps://doi.org/10.1002/9780470939932.ch20openalex-snapshot
High Throughput Screening Techniques in Protein Purification
inferred← citeshttps://doi.org/10.1002/9781119031116.ch11openalex-snapshot
Lab‐Scale Development of Chromatography Processes
inferred← citeshttps://doi.org/10.1002/9781119031116.ch4openalex-snapshot
Simplified Methods Based on Mechanistic Models for Understanding and Designing Chromatography Processes for Proteins and Other Biological Products‐Yamamoto Models and Yamamoto Approach
inferred← citeshttps://doi.org/10.1002/9781119126942.ch1openalex-snapshot
DOWNSTREAM PROCESSING OF MONOCLONAL ANTIBODIES: CURRENT PRACTICES AND FUTURE OPPORTUNITIES
inferred← citeshttps://doi.org/10.1002/9781119126942.ch14openalex-snapshot
INTEGRATED POLISHING STEPS FOR MONOCLONAL ANTIBODY PURIFICATION
inferred← citeshttps://doi.org/10.1002/9781119126942.ch17openalex-snapshot
THE EVOLUTION OF PLATFORM TECHNOLOGIES FOR THE DOWNSTREAM PROCESSING OF ANTIBODIES
inferred← citeshttps://doi.org/10.1002/9781119126942.ch24openalex-snapshot
HIGH‐THROUGHPUT SCREENING AND MODELING TECHNOLOGIES FOR PROCESS DEVELOPMENT IN ANTIBODY PURIFICATION
inferred← citeshttps://doi.org/10.1002/9783527673681.ch17openalex-snapshot
Evaluating the Economic and Operational Feasibility of Continuous Processes for Monoclonal Antibodies
inferred← citeshttps://doi.org/10.1002/9783527673681.ch19openalex-snapshot
The Potential Impact of Continuous Processing on the Practice and Economics of Biopharmaceutical Manufacturing
inferred← citeshttps://doi.org/10.1002/biot.201100475openalex-snapshot
High‐throughput process development of chromatography steps: Advantages and limitations of different formats used
inferred← citeshttps://doi.org/10.1002/biot.201100476openalex-snapshot
Strategic Assay Selection for analytics in high‐throughput process development: Case studies for downstream processing of monoclonal antibodies
inferred← citeshttps://doi.org/10.1002/biot.202300245openalex-snapshot
Improved adeno‐associated virus empty and full capsid separation using weak partitioning multi‐column AEX chromatography
inferred← citeshttps://doi.org/10.1002/bit.21906openalex-snapshot
High‐throughput screening of chromatographic separations: III. Monoclonal antibodies on ceramic hydroxyapatite
inferred← citeshttps://doi.org/10.1002/bit.22127openalex-snapshot
Selective antibody precipitation using polyelectrolytes: A novel approach to the purification of monoclonal antibodies
inferred← citeshttps://doi.org/10.1002/bit.22532openalex-snapshot
Profiling of host cell proteins by two‐dimensional difference gel electrophoresis (2D‐DIGE): Implications for downstream process development
inferred← citeshttps://doi.org/10.1002/bit.23300openalex-snapshot
Cation exchange chromatography provides effective retrovirus clearance for antibody purification processes
inferred← citeshttps://doi.org/10.1002/bit.24539openalex-snapshot
Caprylic acid precipitation method for impurity reduction: An alternative to conventional chromatography for monoclonal antibody purification
inferred← citeshttps://doi.org/10.1002/bit.24781openalex-snapshot
The effect of protein a cycle number on the performance and lifetime of an anion exchange polishing step
inferred← citeshttps://doi.org/10.1002/bit.24869openalex-snapshot
Using high throughput screening to define virus clearance by chromatography resins
inferred← citeshttps://doi.org/10.1002/bit.24898openalex-snapshot
Fouling of an anion exchange chromatography operation in a monoclonal antibody process: Visualization and kinetic studies
inferred← citeshttps://doi.org/10.1002/bit.24955openalex-snapshot
A tandem laboratory scale protein purification process using Protein A affinity and anion exchange chromatography operated in a weak partitioning mode
inferred← citeshttps://doi.org/10.1002/bit.25881openalex-snapshot
High throughput determination of cleaning solutions to prevent the fouling of an anion exchange resin
inferred← citeshttps://doi.org/10.1002/bit.25901openalex-snapshot
High throughput chromatography strategies for potential use in the formal process characterization of a monoclonal antibody
inferred← citeshttps://doi.org/10.1002/bit.28767openalex-snapshot
Tailoring polishing steps for effective removal of polysorbate‐degrading host cell proteins in antibody purification
inferred← citeshttps://doi.org/10.1002/bit.28844openalex-snapshot
Buffer system improves the removal of host cell protein impurities in monoclonal antibody purification
inferred← citeshttps://doi.org/10.1002/bit.70021openalex-snapshot
Manufacturing Process Intensification of Adeno‐Associated Viral Vectors Type‐8 Using Weak Partitioning Chromatography With UV‐Based Process Analytical Technology (PAT)
inferred← citeshttps://doi.org/10.1002/btm2.10061openalex-snapshot
Evolving trends in mAb production processes
inferred← citeshttps://doi.org/10.1002/btpr.1591openalex-snapshot
Strategic assay deployment as a method for countering analytical bottlenecks in high throughput process development: Case studies in ion exchange chromatography
inferred← citeshttps://doi.org/10.1002/btpr.1905openalex-snapshot
A practical strategy for using miniature chromatography columns in a standardized high‐throughput workflow for purification development of monoclonal antibodies
inferred← citeshttps://doi.org/10.1002/btpr.2080openalex-snapshot
Development of a modular virus clearance package for anion exchange chromatography operated in weak partitioning mode
inferred← citeshttps://doi.org/10.1002/btpr.2412openalex-snapshot
Structural and performance characteristics of representative anion exchange resins used for weak partitioning chromatography
inferred← citeshttps://doi.org/10.1002/btpr.2492openalex-snapshot
Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture
inferred← citeshttps://doi.org/10.1002/btpr.2590openalex-snapshot
Bispecific antibody process development: Assembly and purification of knob and hole bispecific antibodies
inferred← citeshttps://doi.org/10.1002/btpr.3139openalex-snapshot
Process and operations strategies to enable global access to antibody therapies
inferred← citeshttps://doi.org/10.1002/btpr.3288openalex-snapshot
Design and optimization of membrane chromatography for monoclonal antibody charge variant separation
inferred← citeshttps://doi.org/10.1002/btpr.3308openalex-snapshot
A high‐throughput approach to developing and optimizing mixed‐mode membrane chromatography for protein purification
inferred← citeshttps://doi.org/10.1002/btpr.3483openalex-snapshot
High‐throughput in silico workflow for optimization and characterization of multimodal chromatographic processes
inferred← citeshttps://doi.org/10.1002/btpr.3523openalex-snapshot
Coupling high‐throughput and modeling approaches to streamline early‐stage process development for biologics
inferred← citeshttps://doi.org/10.1002/btpr.477openalex-snapshot
Downstream antibody purification using aqueous two‐phase extraction
inferred← citeshttps://doi.org/10.1002/btpr.70104openalex-snapshot
A size‐exclusion chromatography fingerprinting workflow for the development of flow‐through polishing operations for mAbs derived from continuous precipitation processes
inferred← citeshttps://doi.org/10.1002/elsc.201400250openalex-snapshot
High‐throughput purification tools for rapid upstream process development are interchangeable for biologics
inferred← citeshttps://doi.org/10.1002/elsc.201400251openalex-snapshot
High‐throughput techniques to evaluate the effect of ligand density for impurity separations with multimodal cation exchange resins
inferred← citeshttps://doi.org/10.1002/elsc.201400255openalex-snapshot
Domain antibody downstream process optimization: High‐throughput strategy and analytical methods
inferred← citeshttps://doi.org/10.1002/jctb.2125openalex-snapshot
Review: Microscale methods for high‐throughput chromatography development in the pharmaceutical industry
inferred← citeshttps://doi.org/10.1007/10_2012_174openalex-snapshot
Extreme Scale-Down Approaches for Rapid Chromatography Column Design and Scale-Up During Bioprocess Development
inferred← citeshttps://doi.org/10.1007/10_2017_12openalex-snapshot
Downstream Processing Technologies/Capturing and Final Purification
inferred← citeshttps://doi.org/10.1007/978-1-0716-1450-1_10openalex-snapshot
Ion Exchange Chromatographic Methods for Purification of Therapeutic Antibodies
inferred← citeshttps://doi.org/10.1007/978-1-4939-8958-4_7openalex-snapshot
Purification of Human Monoclonal Antibodies and Their Fragments
inferred← citeshttps://doi.org/10.1007/978-1-62703-586-6_17openalex-snapshot
Purification of Human Monoclonal Antibodies and Their Fragments
inferred← citeshttps://doi.org/10.1007/978-94-007-1257-7_14openalex-snapshot
Recovery and Purification of Antibody
inferred← citeshttps://doi.org/10.1007/978-94-007-4026-6_1openalex-snapshot
Separation of Amino Acids, Peptides, and Proteins by Ion Exchange Chromatography
inferred← citeshttps://doi.org/10.1016/b978-0-08-088504-9.00239-7openalex-snapshot
Process Validation
inferred← citeshttps://doi.org/10.1016/b978-0-08-100623-8.00016-5openalex-snapshot
Introduction to Preparative Protein Chromatography
inferred← citeshttps://doi.org/10.1016/b978-0-08-100623-8.00018-9openalex-snapshot
Ion Exchange Chromatography
inferred← citeshttps://doi.org/10.1016/b978-0-08-100623-8.00034-7openalex-snapshot
The Search for Process Intensification and Simplification: Alternative Approaches versus Current Platform Processes for Monoclonal Antibodies
inferred← citeshttps://doi.org/10.1016/b978-0-08-100623-8.00039-6openalex-snapshot
Next-Generation Process Design for Monoclonal Antibody Purification
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12419-9openalex-snapshot
Evolution of mAb Downstream Process Platforms
inferred← citeshttps://doi.org/10.1016/b978-0-443-15369-3.00005-5openalex-snapshot
Separation of proteins by ion-exchange chromatography
inferred← citeshttps://doi.org/10.1016/b978-0-444-64046-8.00184-1openalex-snapshot
Process Validation
inferred← citeshttps://doi.org/10.1016/j.ab.2024.115692openalex-snapshot
The downstream purification of bispecific antibodies
inferred← citeshttps://doi.org/10.1016/j.bej.2012.02.003openalex-snapshot
Application of genetic algorithms and response surface analysis for the optimization of batch chromatographic systems
inferred← citeshttps://doi.org/10.1016/j.bej.2024.109378openalex-snapshot
Process optimization and economic evaluation of continuous multi-column capture for monoclonal antibody – A case study
inferred← citeshttps://doi.org/10.1016/j.bej.2024.109476openalex-snapshot
Stepwise cell culture process intensification for high-productivity and cost-effective commercial manufacturing of a Mabcalin™ bispecifics
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2015.04.010openalex-snapshot
Extraction and downstream processing of plant-derived recombinant proteins
inferred← citeshttps://doi.org/10.1016/j.chroma.2009.05.021openalex-snapshot
Comparison of agarose and dextran-grafted agarose strong ion exchangers for the separation of protein aggregates
inferred← citeshttps://doi.org/10.1016/j.chroma.2009.09.038openalex-snapshot
A microscale approach for predicting the performance of chromatography columns used to recover therapeutic polyclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.chroma.2009.09.040openalex-snapshot
Binding and elution behavior of proteins on strong cation exchangers
inferred← citeshttps://doi.org/10.1016/j.chroma.2011.06.043openalex-snapshot
Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium
inferred← citeshttps://doi.org/10.1016/j.chroma.2011.08.008openalex-snapshot
Exploration of overloaded cation exchange chromatography for monoclonal antibody purification
inferred← citeshttps://doi.org/10.1016/j.chroma.2011.09.008openalex-snapshot
Separation science is the key to successful biopharmaceuticals
inferred← citeshttps://doi.org/10.1016/j.chroma.2011.10.034openalex-snapshot
Technology trends in antibody purification
inferred← citeshttps://doi.org/10.1016/j.chroma.2013.01.006openalex-snapshot
Structure and protein adsorption mechanisms of clean and fouled tentacle-type anion exchangers used in a monoclonal antibody polishing step
inferred← citeshttps://doi.org/10.1016/j.chroma.2013.01.065openalex-snapshot
Void exclusion of antibodies by grafted-ligand porous particle anion exchangers
inferred← citeshttps://doi.org/10.1016/j.chroma.2013.01.082openalex-snapshot
Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture
inferred← citeshttps://doi.org/10.1016/j.chroma.2014.03.010openalex-snapshot
Nonspecific interactions of chromatin with immunoglobulin G and protein A, and their impact on purification performance
inferred← citeshttps://doi.org/10.1016/j.chroma.2015.12.071openalex-snapshot
The rapid identification of elution conditions for therapeutic antibodies from cation-exchange chromatography resins using high-throughput screening
inferred← citeshttps://doi.org/10.1016/j.chroma.2017.03.063openalex-snapshot
Monoclonal antibody fragment removal mediated by mixed mode resins
inferred← citeshttps://doi.org/10.1016/j.chroma.2018.02.018openalex-snapshot
Parallel loading and complete automation of a 3-step mAb purification process for multiple samples using a customized preparative chromatography instrument with networked pumps
inferred← citeshttps://doi.org/10.1016/j.chroma.2018.07.028openalex-snapshot
Evaluation of chromatofocusing as a capture method for monoclonal antibody products
inferred← citeshttps://doi.org/10.1016/j.chroma.2019.03.005openalex-snapshot
High throughput process development workflow with advanced decision-support for antibody purification
inferred← citeshttps://doi.org/10.1016/j.chroma.2019.05.056openalex-snapshot
Mechanistic modeling based process development for monoclonal antibody monomer-aggregate separations in multimodal cation exchange chromatography
inferred← citeshttps://doi.org/10.1016/j.chroma.2020.461537openalex-snapshot
Automated pH and conductivity conditioning using feedback control to support a two-step continuous purification process
inferred← citeshttps://doi.org/10.1016/j.chroma.2020.461635openalex-snapshot
Impact of virus-antibody interactions on viral clearance in anion exchange chromatography
inferred← citeshttps://doi.org/10.1016/j.chroma.2021.462788openalex-snapshot
Behavior of weakly adsorbing protein impurities in flow-through ion-exchange chromatography
inferred← citeshttps://doi.org/10.1016/j.chroma.2023.463878openalex-snapshot
Isotherm model discrimination for multimodal chromatography using mechanistic models derived from high-throughput batch isotherm data
inferred← citeshttps://doi.org/10.1016/j.chroma.2024.465114openalex-snapshot
Competitive Protein Adsorption in Isocratic Anion Exchange Chromatography
inferred← citeshttps://doi.org/10.1016/j.chroma.2024.465229openalex-snapshot
Improved clearance of host cell protein impurities at the polishing purification step using multimodal chromatography
inferred← citeshttps://doi.org/10.1016/j.chroma.2025.465730openalex-snapshot
Defining operating regimes for partition coefficient measurements in protein chromatography
inferred← citeshttps://doi.org/10.1016/j.chroma.2026.466715openalex-snapshot
Integrating hybrid modeling and high throughput screening: A modular process development platform for flowthrough chromatography
inferred← citeshttps://doi.org/10.1016/j.chroma.2026.466900openalex-snapshot
Accelerating chromatography process development: A hybrid approach to model hydrophobic interaction column based on high-throughput automated isotherm characterization
inferred← citeshttps://doi.org/10.1016/j.chroma.2026.467325openalex-snapshot
A modeling framework for uncertainty quantification in filter-plate-based high-throughput screening of the chromatography partition coefficient
inferred← citeshttps://doi.org/10.1016/j.coche.2011.08.008openalex-snapshot
Downstream bioprocessing: recent advances and future promise
inferred← citeshttps://doi.org/10.1016/j.coche.2014.08.004openalex-snapshot
High throughput process development in biomanufacturing
inferred← citeshttps://doi.org/10.1016/j.coche.2018.09.001openalex-snapshot
Current status and future challenges in continuous biochromatography
inferred← citeshttps://doi.org/10.1016/j.coche.2022.100813openalex-snapshot
Opportunities and challenges for model utilization in the biopharmaceutical industry: current versus future state
inferred← citeshttps://doi.org/10.1016/j.ejpb.2011.03.004openalex-snapshot
Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation development
inferred← citeshttps://doi.org/10.1016/j.jbiotec.2017.12.018openalex-snapshot
Evaluating the effect of in-process material on the binding mechanisms of surrogate viral particles to a multi-modal anion exchange resin
inferred← citeshttps://doi.org/10.1016/j.jchromb.2023.123767openalex-snapshot
Effectively removing the homodimer in bispecific antibodies by weak partitioning mode of anion exchange chromatography
inferred← citeshttps://doi.org/10.1016/j.jchromb.2025.124796openalex-snapshot
Efficient host cell protein clearance: A study of membrane adsorbers and resins in biopharmaceutical processes
inferred← citeshttps://doi.org/10.1016/j.jcoa.2025.100300openalex-snapshot
Chromatography on monolithic supports for biological nanoparticles and large biomolecules: Recent developments and state-of-the-art
inferred← citeshttps://doi.org/10.1016/j.memsci.2011.11.049openalex-snapshot
Simultaneous removal of leached protein-A and aggregates from monoclonal antibody using hydrophobic interaction membrane chromatography
inferred← citeshttps://doi.org/10.1016/j.pep.2015.12.018openalex-snapshot
Extraction and purification methods in downstream processing of plant-based recombinant proteins
inferred← citeshttps://doi.org/10.1016/j.pep.2017.04.006openalex-snapshot
Effective strategies for host cell protein clearance in downstream processing of monoclonal antibodies and Fc-fusion proteins
inferred← citeshttps://doi.org/10.1016/j.pep.2021.105927openalex-snapshot
Removing a light-chain missing byproduct by MMC ImpRes mixed-mode chromatography under weak partitioning mode in purifying a WuXiBody-based bispecific antibody
inferred← citeshttps://doi.org/10.1016/j.pep.2023.106297openalex-snapshot
Resin and loading condition screening for effective and robust byproducts removal by anion exchange chromatography: A case study
inferred← citeshttps://doi.org/10.1016/j.pep.2024.106583openalex-snapshot
Partition coefficient screening – An effective approach for finding the best conditions for byproduct removal as demonstrated by a bispecific antibody purification case
inferred← citeshttps://doi.org/10.1016/j.seppur.2020.117890openalex-snapshot
Removal of host cell proteins from cell culture fluids by weak partitioning chromatography using peptide-based adsorbents
inferred← citeshttps://doi.org/10.1016/j.snb.2017.09.167openalex-snapshot
A regenerable microfluidic device with integrated valves and thin-film photodiodes for rapid optimization of chromatography conditions
inferred← citeshttps://doi.org/10.1016/j.tibtech.2010.02.001openalex-snapshot
Recent advances in large-scale production of monoclonal antibodies and related proteins
inferred← citeshttps://doi.org/10.1017/9781108332897openalex-snapshot
Continuous Biopharmaceutical Processes
inferred← citeshttps://doi.org/10.1017/9781108332897.001openalex-snapshot
Preface
inferred← citeshttps://doi.org/10.1017/9781108332897.002openalex-snapshot
Introduction to Biopharmaceutical Processes
inferred← citeshttps://doi.org/10.1017/9781108332897.003openalex-snapshot
Fundamentals of Protein Chromatography
inferred← citeshttps://doi.org/10.1017/9781108332897.004openalex-snapshot
Countercurrrent Separation Processes
inferred← citeshttps://doi.org/10.1017/9781108332897.005openalex-snapshot
Countercurrent Chromatography for the Capture Step
inferred← citeshttps://doi.org/10.1017/9781108332897.006openalex-snapshot
Countercurrent Chromatography for the Polishing Steps
inferred← citeshttps://doi.org/10.1017/9781108332897.007openalex-snapshot
Protein Conjugation
inferred← citeshttps://doi.org/10.1017/9781108332897.008openalex-snapshot
Protein Aggregation in Biopharmaceutical Processes
inferred← citeshttps://doi.org/10.1017/9781108332897.009openalex-snapshot
Conclusion
inferred← citeshttps://doi.org/10.1017/9781108332897.010openalex-snapshot
Bibliography
inferred← citeshttps://doi.org/10.1017/9781108332897.011openalex-snapshot
Index
inferred← citeshttps://doi.org/10.1038/s41587-020-0512-5openalex-snapshot
Developing therapeutic monoclonal antibodies at pandemic pace
inferred← citeshttps://doi.org/10.1080/01496395.2010.511641openalex-snapshot
Microfluidic Chromatography for Early Stage Evaluation of Biopharmaceutical Binding and Separation Conditions
inferred← citeshttps://doi.org/10.1093/abt/tbad028openalex-snapshot
Challenges and solutions for the downstream purification of therapeutic proteins
inferred← citeshttps://doi.org/10.1186/s40643-024-00827-8openalex-snapshot
Non-affinity platform for processing knob-into-hole bispecific antibody
inferred← citeshttps://doi.org/10.18130/v3031qopenalex-snapshot
Understanding Process Performance Parameters in a Two-Step Monoclonal Antibody Chromatographic Purification Process
inferred← citeshttps://doi.org/10.18130/v3d94nopenalex-snapshot
Protein Adsorption in Tentacle-Type Anion Exchangers and the Influence of Process Related Fouling
inferred← citeshttps://doi.org/10.20448/2003.82.91.97openalex-snapshot
Teaching Biology in Primary Education
inferred← citeshttps://doi.org/10.21203/rs.3.rs-4469694/v1openalex-snapshot
A Non-Affinity Platform for Processing Knob-into-Hole Bispecific Antibody
inferred← citeshttps://doi.org/10.22214/ijraset.2022.47235openalex-snapshot
A Review on Downstream Processing of Monoclonal Antibodies (mAbs)
inferred← citeshttps://doi.org/10.22270/jddt.v9i4.3117openalex-snapshot
Analytical Techniques in Pharmaceutical Analysis for Samples Separation, Characterization, Determination and its Handling
inferred← citeshttps://doi.org/10.3389/fbioe.2024.1490276openalex-snapshot
Polysorbates degrading enzymes in biotherapeutics – a current status and future perspectives
inferred← citeshttps://doi.org/10.3390/antib4030157openalex-snapshot
Model-Based Comparison of Antibody Dimerization in Continuous and Batch-Wise Downstream Processing
inferred← citeshttps://doi.org/10.34172/apb.43967openalex-snapshot
Purification technologies of monoclonal antibodies: chromatographic methods
inferred← citeshttps://doi.org/10.3769/radioisotopes.68.451openalex-snapshot
Effect of Dose on Amount of Protein Adsorbed on Anion-Exchange Fibers Prepared by Radiation-Induced Emulsion Graft Polymerization
inferred← citeshttps://doi.org/10.4018/978-1-6684-8551-4.ch004openalex-snapshot
The Utilization of Digital Educational Content in the Teaching of Sciences in Elementary School as Impactful Learning Experiences
inferred← citeshttps://doi.org/10.4155/pbp.15.28openalex-snapshot
Development of an acidic/neutral antibody flow-through polishing step using salt-tolerant anion exchange chromatography
inferred← citeshttps://doi.org/10.4161/mabs.2.5.12645openalex-snapshot
Recovery and purification process development for monoclonal antibody production
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.